Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas

Pretargeted radioimmunotherapy (PRIT) using streptavidin (SA)–conjugated antibodies (Abs), followed by clearing agent and radiolabeled biotin is a promising method that can increase the effectiveness of RIT, while decreasing the toxicities associated with directly labeled Abs. Although CD20 has been...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pantelias, Anastasia, Pagel, John M., Hedin, Nathan, Saganic, Laura, Wilbur, Shani, Hamlin, Donald K., Wilbur, D. Scott, Lin, Yukang, Stone, Diane, Axworthy, Don, Gopal, Ajay K., Press, Oliver W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885529/
https://ncbi.nlm.nih.gov/pubmed/17303693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-11-056895
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados